Log in

NASDAQ:APYXApyx Medical Stock Price, Forecast & News

$5.32
-0.10 (-1.85 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.16
Now: $5.32
$5.52
50-Day Range
$4.07
MA: $4.87
$5.69
52-Week Range
$2.81
Now: $5.32
$8.59
Volume66,300 shs
Average Volume183,737 shs
Market Capitalization$181.84 million
P/E RatioN/A
Dividend YieldN/A
Beta0.8
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.02 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APYX
CUSIPN/A
CIKN/A
Phone727-384-2323

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$28.15 million
Book Value$2.09 per share

Profitability

Net Income$-19,710,000.00

Miscellaneous

Employees222
Market Cap$181.84 million
Next Earnings Date8/10/2020 (Confirmed)
OptionableOptionable

Receive APYX News and Ratings via Email

Sign-up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter.

Apyx Medical (NASDAQ:APYX) Frequently Asked Questions

How has Apyx Medical's stock been impacted by COVID-19 (Coronavirus)?

Apyx Medical's stock was trading at $5.06 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, APYX shares have increased by 5.1% and is now trading at $5.32. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Apyx Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Apyx Medical.

When is Apyx Medical's next earnings date?

Apyx Medical is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Apyx Medical.

How can I listen to Apyx Medical's earnings call?

Apyx Medical will be holding an earnings conference call on Monday, August 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Apyx Medical's earnings last quarter?

Apyx Medical Corp (NASDAQ:APYX) posted its earnings results on Monday, May, 11th. The company reported ($0.20) EPS for the quarter, topping the consensus estimate of ($0.25) by $0.05. The business earned $5 million during the quarter, compared to the consensus estimate of $5.29 million. Apyx Medical had a negative return on equity of 21.45% and a negative net margin of 58.26%. View Apyx Medical's earnings history.

What price target have analysts set for APYX?

2 equities research analysts have issued 12-month price targets for Apyx Medical's shares. Their forecasts range from $5.00 to $10.00. On average, they anticipate Apyx Medical's stock price to reach $7.33 in the next twelve months. This suggests a possible upside of 37.8% from the stock's current price. View analysts' price targets for Apyx Medical.

Has Apyx Medical been receiving favorable news coverage?

News articles about APYX stock have trended negative this week, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Apyx Medical earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Apyx Medical.

Are investors shorting Apyx Medical?

Apyx Medical saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 395,200 shares, a decline of 11.0% from the June 15th total of 443,800 shares. Based on an average trading volume of 129,600 shares, the short-interest ratio is currently 3.0 days. Approximately 1.3% of the shares of the company are sold short. View Apyx Medical's Current Options Chain.

Who are some of Apyx Medical's key competitors?

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), Wells Fargo & Co (WFC), Amgen (AMGN), Broadcom (AVGO), Alibaba Group (BABA), Bank of America (BAC) and Corbus Pharmaceuticals (CRBP).

Who are Apyx Medical's key executives?

Apyx Medical's management team includes the following people:
  • Mr. Charles D. Goodwin II, Pres, CEO & Director (Age 53)
  • Ms. Tara H. Semb, CFO, Treasurer & Sec. (Age 49)
  • Mr. Moshe Citronowicz, Sr. VP (Age 66)
  • Mr. Todd Hornsby, Exec. VP (Age 43)

What is Apyx Medical's stock symbol?

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

How do I buy shares of Apyx Medical?

Shares of APYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Apyx Medical's stock price today?

One share of APYX stock can currently be purchased for approximately $5.32.

How big of a company is Apyx Medical?

Apyx Medical has a market capitalization of $181.84 million and generates $28.15 million in revenue each year. The company earns $-19,710,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. Apyx Medical employs 222 workers across the globe.

What is Apyx Medical's official website?

The official website for Apyx Medical is www.apyxmedical.com.

How can I contact Apyx Medical?

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The company can be reached via phone at 727-384-2323 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.